No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Ramoplanin is an antibiotic used to treat a variety of bacterial infections. It is a glycolipodepsipeptide antibiotic, derived from the bacterium Actinoplanes utahensis. It is active against a wide range of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Ramoplanin is used to treat infections of the skin, respiratory tract, and urinary tract. It is also used to prevent infections in patients undergoing surgery or other medical procedures.
Ramoplanin is available in both oral and intravenous formulations. It is generally well tolerated, with few side effects. The most common side effects are nausea, vomiting, and diarrhea.
The Ramoplanin market is a growing segment of the antibiotics market. It is used to treat a variety of bacterial infections, and is particularly effective against MRSA. The increasing prevalence of antibiotic-resistant bacteria is driving demand for Ramoplanin and other antibiotics.
Companies in the Ramoplanin market include AstraZeneca, Merck, Pfizer, and GlaxoSmithKline. Show Less Read more
